- About Us
-
Our Business
-
- Therapeutic Areas Our portfolio is diverse and based upon - Market Research, Regulatory & IP.
- Licensing Licensing activities are excellent opportunities for companies to expand their portfolio.
- Biosimilar Biosimilar are biologic medicines that are developed to match their reference medicine.
-
- CRAM India has grown to be one of the key nations complying GMP manufacturing norms.
- Medical Devices REVA help our clients to deliver customized, cost-effective medical device value chain.
-
API
-
Dosage form
-
-
Operations
- At Reva, we have requisite infrastructure, with a balanced reach across Regulated, Emerging & Expansion markets. And we are committed to helping create healthier communities worldwide through education, outreach and better access to treatment.
-
Research & Development
-
Manufacturing
-
Quality
- Media
- Contact us
Latest News
A new pill that could prevent pre-eclampsia has become the first pregnancy drug to be fast-tracked for development by...
Read More
Read More
The Drug Controller Office, UT, has filed a case in a local court against the directors and other officials of a...
Read More
Read More
The last few months have seen several drugmakers outline remedial measures that they are undertaking, following action...
Read More
Read More
Vaccine maker Novavax Inc (NVAX.O) said on Tuesday its COVID-19 shot retooled against the Omicron BA.1 variant showed a...
Read More
Read More
A high-level panel of experts set up by the Narendra Modi government is meeting pharmaceutical industry officials this...
Read More
Read More
At a village clinic in central Congo, separated from the world by a tangle of waterways and forests, six-year-old...
Read More
Read More
Alembic Pharmaceuticals on Thursday said it has received final approval from the US health regulator for its generic...
Read More
Read More
Global deaths from tuberculosis are estimated to have increased between 2019 and 2021, reversing years of decline as the...
Read More
Read More
The Hyderabad Pharma City (HPC), a mega pharma park developed by the Telangana Government, is likely to be launched...
Read More
Read More
Dr Dilip Mahalanabis was working in overflowing refugee camps during the 1971 Bangladesh Liberation war when he came up...
Read More
Read More
The Serum Institute of India plans to manufacture 20,000 to 30,000 doses of an experimental Ebola vaccine by the end of...
Read More
Read More
Bill & Melinda Gates Foundation said on Sunday that it will commit $1.2 billion to support efforts to end all forms of...
Read More
Read More